Rohto Pharmaceutical Co Ltd
TSE:4527
Rohto Pharmaceutical Co Ltd
Other Operating Expenses
Rohto Pharmaceutical Co Ltd
Other Operating Expenses Peer Comparison
Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Other Operating Expenses
-¥1m
|
CAGR 3-Years
84%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Shiseido Co Ltd
TSE:4911
|
Other Operating Expenses
¥11.7B
|
CAGR 3-Years
80%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pola Orbis Holdings Inc
TSE:4927
|
Other Operating Expenses
-¥1m
|
CAGR 3-Years
21%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Kao Corp
TSE:4452
|
Other Operating Expenses
-¥6.8B
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
F
|
Fancl Corp
TSE:4921
|
Other Operating Expenses
-¥1m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Other Operating Expenses
-¥1m
|
CAGR 3-Years
21%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
See Also
What is Rohto Pharmaceutical Co Ltd's Other Operating Expenses?
Other Operating Expenses
-1m
JPY
Based on the financial report for Mar 31, 2024, Rohto Pharmaceutical Co Ltd's Other Operating Expenses amounts to -1m JPY.
What is Rohto Pharmaceutical Co Ltd's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 3Y
84%
Over the last year, the Other Operating Expenses growth was 0%. The average annual Other Operating Expenses growth rates for Rohto Pharmaceutical Co Ltd have been 84% over the past three years .